These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 21284696)

  • 1. Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.
    Praharaj SK; Jana AK; Goyal N; Sinha VK
    Br J Clin Pharmacol; 2011 Mar; 71(3):377-82. PubMed ID: 21284696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
    Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
    JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
    Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
    Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial.
    Baptista T; Rangel N; Fernández V; Carrizo E; El Fakih Y; Uzcátegui E; Galeazzi T; Gutiérrez MA; Servigna M; Dávila A; Uzcátegui M; Serrano A; Connell L; Beaulieu S; de Baptista EA
    Schizophr Res; 2007 Jul; 93(1-3):99-108. PubMed ID: 17490862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.
    Citrome L; Holt RI; Walker DJ; Hoffmann VP
    Clin Drug Investig; 2011; 31(7):455-82. PubMed ID: 21495734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder.
    Kemp DE; Zhao J; Cazorla P; Landbloom RP; Mackle M; Snow-Adami L; Szegedi A
    J Clin Psychiatry; 2014 Mar; 75(3):238-45. PubMed ID: 24499969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
    de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
    J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study.
    Baptista T; Uzcátegui E; Rangel N; El Fakih Y; Galeazzi T; Beaulieu S; de Baptista EA
    Psychiatry Res; 2008 May; 159(1-2):250-3. PubMed ID: 18374423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Naturalistic Randomized Placebo-Controlled Trial of Extended-Release Metformin to Prevent Weight Gain Associated With Olanzapine in a US Community-Dwelling Population.
    Rado J; von Ammon Cavanaugh S
    J Clin Psychopharmacol; 2016 Apr; 36(2):163-8. PubMed ID: 26872112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study.
    Wang M; Tong JH; Zhu G; Liang GM; Yan HF; Wang XZ
    Schizophr Res; 2012 Jun; 138(1):54-7. PubMed ID: 22398127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight gain during treatment of bipolar I patients with olanzapine.
    Hennen J; Perlis RH; Sachs G; Tohen M; Baldessarini RJ
    J Clin Psychiatry; 2004 Dec; 65(12):1679-87. PubMed ID: 15641874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis.
    Siskind DJ; Leung J; Russell AW; Wysoczanski D; Kisely S
    PLoS One; 2016; 11(6):e0156208. PubMed ID: 27304831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.
    Moteshafi H; Zhornitsky S; Brunelle S; Stip E
    Drug Saf; 2012 Oct; 35(10):819-36. PubMed ID: 22967188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
    Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
    Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mostafavi SA; Solhi M; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):440-444. PubMed ID: 28339282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled open-label study.
    Hoffmann VP; Case M; Jacobson JG
    J Clin Psychiatry; 2012 Feb; 73(2):216-23. PubMed ID: 21672497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis.
    de Silva VA; Suraweera C; Ratnatunga SS; Dayabandara M; Wanniarachchi N; Hanwella R
    BMC Psychiatry; 2016 Oct; 16(1):341. PubMed ID: 27716110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.